BRISTOL-MYERS SQUIBB COMPANY
Patent Owner
Back to search results Back to News FeedStats
- 0 2,041 US PATENTS IN FORCE
- 29 US APPLICATIONS PENDING
- Mar 20, 2018 most recent publication
Details
- 2,041 Issued Patents
- 19 Issued in last 3 years
- 2 Published in last 3 years
- 44,531 Total Citation Count
- Jun 27, 1975 Earliest Filing
- 1,669 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
MATTERS
Rank in Class
Intl Class
Technology
MATTERS
Rank in Class
- No Technologies to Display
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Patent #
Title
Filing Date
Issue Date
Intl Class
CITATIONS
5508272
Compounds containing a fused bicycle ring and processes therefor
May 05, 94
Apr 16, 96
[C07D, A61K]
149
6818418
Protein scaffolds for antibody mimics and other binding proteins
Feb 29, 00
Nov 16, 04
[A61K]
123
5760246
Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method
Dec 17, 96
Jun 02, 98
[C07D]
120
5595872
Nucleic acids encoding microsomal trigyceride transfer protein
Sep 03, 93
Jan 21, 97
[C12N, C07H, C12Q]
117
6548529
Heterocyclic containing biphenyl aP2 inhibitors and method
Mar 06, 00
Apr 15, 03
[C07D, A61K]
111
- No Patents to Display
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2018/0037,921
ANTIBODIES CONJUGATABLE BY TRANSGLUTAMINASE AND CONJUGATES MADE THEREFROM
Mar 01, 16
Feb 08, 18
[C12P, A61K, C07K]
2018/0030,057
SUBSTITUTED IMIDAZO[1,5-a]PYRAZINES AS CGRP RECEPTOR ANTAGONISTS
Sep 21, 17
Feb 01, 18
[C07D]
2017/0368,172
USE OF ANTI-PD-1 ANTIBODY IN COMBINATION WITH ANTI-CD27 ANTIBODY IN CANCER TREATMENT
Jun 03, 17
Dec 28, 17
[A61K, C07K]
2017/0334,958
PROTEIN SCAFFOLDS FOR ANTIBODY MIMICS AND OTHER BINDING PROTEINS
May 01, 17
Nov 23, 17
[C12N, C40B, C12Q, C07K]
2017/0326,249
ANTIBODY-DRUG CONJUGATE OF AN ANTI-GLYPICAN-3 ANTIBODY AND A TUBULYSIN ANALOG, PREPARATION AND USES
May 05, 17
Nov 16, 17
[A61K, C07K]
2017/0247,343
THIOETHER TRIAZOLOPYRIDINE AND TRIAZOLOPYRIMIDINE INHIBITORS OF MYELOPEROXIDASE
Sep 09, 15
Aug 31, 17
[C07D, A61K]
2017/0247,466
TREATMENT OF LUNG CANCER USING AN ANTI-FUCOSYL-GM1 ANTIBODY
Sep 24, 15
Aug 31, 17
[A61K, C07K]
2017/0158,776
TREATMENT OF LUNG CANCER USING A COMBINATION OF AN ANTI-PD-1 ANTIBODY AND ANOTHER ANTI-CANCER AGENT
May 15, 15
Jun 08, 17
[A61K, C07K]
- No Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9920036
Cyanoamino (aza)benzofuran compounds for the treatment of hepatitis C
Mar 20, 15
Mar 20, 18
[C07D, A61P, A61K]
9920075
Triazolopyridine and triazolopyrimidine inhibitors of myeloperoxidase
Sep 09, 15
Mar 20, 18
[C07D, A61K]
9920108
Targeted therapeutics based on engineered proteins that bind EGFR
Nov 30, 15
Mar 20, 18
[A61K, C07K]
9914739
6H-furo[2,3-E]indole compounds for the treatment of hepatitis C
Mar 20, 15
Mar 13, 18
[C07D, C07B]
9908937
Compositions monovalent for CD28 binding and methods of use
Jun 16, 15
Mar 06, 18
[A61K, C07K]
9901572
Aryl dihydropyridinones and piperidinone MGAT2 inhibitors
Apr 17, 17
Feb 27, 18
[C07F, C07D, A61K]
- No Patents to Display
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2017/0260,232
TUBULYSIN COMPOUNDS, METHODS OF MAKING AND USE
Abandoned
May 23, 17
Sep 14, 17
[A61K, C07K]
2017/0057,961
MACROCYCLIC FACTOR XIA INHIBITORS CONDENSED WITH HETEROCYCLES
Abandoned
Jan 30, 15
Mar 02, 17
[C07D]
2016/0347,836
TREATMENT OF HODGKIN'S LYMPHOMA USING AN ANTI-PD-1 ANTIBODY
Abandoned
May 26, 16
Dec 01, 16
[C12Q, A61K, G01N, C07K]
2016/0326,248
ANTI-LAG-3 ANTIBODIES TO TREAT HEMATOLOGICAL MALIGNANCIES
Abandoned
Jan 26, 15
Nov 10, 16
[C07K]
2016/0318,904
SUBSTITUTED TETRAHYDROISOQUINOLINE COMPOUNDS AS FACTOR XIA INHIBITORS
Abandoned
Jul 08, 16
Nov 03, 16
[C07D]
2016/0304,607
COMPOSITIONS COMPRISING A COMBINATION OF AN ANTI-PD-1 ANTIBODY AND ANOTHER ANTIBODY
Abandoned
Apr 15, 16
Oct 20, 16
[C07K]
2016/0274,108
DIAGNOSTIC METHODS FOR PAR4 ANTAGONIST THERAPY
Abandoned
Oct 24, 14
Sep 22, 16
[A61K, G01N]
2016/0152,686
FIBRONECTIN BASED SCAFFOLD DOMAINS LINKED TO SERUM ALBUMIN OR MOIETY BINDING THERETO
Abandoned
Mar 12, 14
Jun 02, 16
[C07K]
2016/0153,990
METHODS FOR IDENTIFYING PATIENTS AT RISK FOR COSTIMULATION BLOCKADE RESISTANT REJECTION
Abandoned
Mar 27, 14
Jun 02, 16
[G01N]
2016/0038,502
HIV TREATMENT FORMULATION OF ATAZANAVIR AND COBICISTAT
Abandoned
Oct 06, 14
Feb 11, 16
[A61K]
2015/0336,975
COMPOUNDS FOR THE REDUCTION OF BETA-AMYLOID PRODUCTION
Abandoned
Aug 03, 15
Nov 26, 15
[C07D]
2015/0322,119
ENHANCING ANTI-CANCER ACTIVITY OF IMMUNOMODULATORY FC FUSION PROTEINS
Abandoned
Dec 03, 13
Nov 12, 15
[C07K]
2015/0299,804
BIOMARKERS FOR PREDICTING CLINICAL RESPONSE OF CANCER PATIENTS TO TREATMENT WITH IMMUNOTHERAPEUTIC AGENT
Abandoned
Nov 14, 13
Oct 22, 15
[C12Q, G06F, C07K]
2015/0297,603
HIGH DRUG LOAD TABLET FORMULATION OF [(1R), 2S]-2-AMINOPROPIONIC ACID 2-[4-(4-FLUORO-2-METHYL-1H-INDOL-5-YLOXY)-5-METHYLPYRROLO[2,1-f][1,2,4]TRIAZIN-6-YLOXY]-1-METHYLETHYL ESTER
Abandoned
Jun 30, 15
Oct 22, 15
[A61K]
2015/0290,316
COMBINATION OF ANTI-KIR ANTIBODIES AND ANTI-PD-1 ANTIBODIES TO TREAT CANCER
Abandoned
Oct 02, 13
Oct 15, 15
[A61K, C07K]
- No Patents to Display
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
Inventor Name
Address
MATTERS
- No Inventor to Display
Free |
Premium |
Professional |
Enterprise |
Patent Searching | ![]() |
![]() |
![]() |
![]() |
|||
Technology Searching | ![]() |
![]() |
![]() |
![]() |
|||
Owner and Inventor Searching | ![]() |
![]() |
![]() |
![]() |
|||
Patent Analytics | ![]() |
![]() |
![]() |
![]() |
|||
Owner Analytics | ![]() |
![]() |
![]() |
![]() |
|||
Attorney Analytics | ![]() |
![]() |
![]() |
![]() |
|||
Inventor Analytics | ![]() |
![]() |
![]() |
![]() |
|||
Technology Analytics | ![]() |
![]() |
![]() |
![]() |
|||
Mobile Searching | ![]() |
![]() |
![]() |
![]() |
|||
Tagging | ![]() |
![]() |
![]() |
||||
Advanced Patent Analytics | ![]() |
![]() |
![]() |
||||
Advanced Owner Analytics | ![]() |
![]() |
![]() |
||||
Mobile Portfolio/Analytics | ![]() |
![]() |
![]() |
||||
Detailed Attorney Information | ![]() |
![]() |
|||||
Prosecution analytics | ![]() |
![]() |
|||||
Pre-publication Data | ![]() |
![]() |
|||||
Monthly PAIR Information and Watches | ![]() |
![]() |
|||||
Number of patents in all portfolios | 100 (maximum) | 1000 (maximum) | 2000 (maximum) | Unlimited | |||
Watches in all categories (Watch) | 20 (maximum) | 10 (maximum) | 50 (maximum) | 500 (maximum) | Unlimited | ||
Maximum number of portfolios | 5 (maximum) | 10 (maximum) | 100 (maximum) | Unlimited | |||
Maximum number of comparisons | 1 (maximum) | 5 (maximum) | 20 (maximum) | Unlimited |
FREE |
$9.95/mo |
$39.95/mo |
$99.95/mo |
||||
PAIR Watch Weekly Update | $2.75/mo/patent | $2.65/mo/patent | |||||
PAIR Watch Daily Update | $5.75/mo/patent | $5.65/mo/patent | |||||
Trial Version | Trial Version | Trial Version | |||||
Current Plan Upgrade Now | Current Plan Upgrade Now | Current Plan Upgrade Now | Current Plan Upgrade Now |
We are sorry but your current membership does not allow you access to this feature. Upgrade to our Premium Level to View Top Owners in Class/Subclass! Learn More |